Skip to main content
. Author manuscript; available in PMC: 2012 Apr 7.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):558–564. doi: 10.1097/QAI.0b013e3181ee3d82

FIGURE 3.

FIGURE 3

Adverse events occurring in ≥5% of patients at end of blinded therapy. Includes all patients who received at least 1 dose of study medication. If the same patient in a given treatment had more than 1 occurrence in the same preferred term event category, only the most severe occurrence is taken. Event counts are adjusted to 100 years of patient exposure. Includes data up to 7 days after last dose of study drug. RTI, respiratory tract infection.